chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Full blood count, Lumbar puncture, Malaise, Meningitis, Pyrexia
Clinical narrative: Initial report received from a non-healthcare professional (patient's parent) on 25 November 2013. A 19-month-old male patient whose medical history and concomitant medication were not reported, had received a dose of flu vaccine (lot number, dose number, route and anatomical site of administration were not reported) on 15 October year not reported. The patient was healthy at the time of vaccination. 35 days later on an unspecified date, the patient died. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Urine analysis, White blood cell count normal
Clinical narrative: Initial report received from a non-healthcare professional (patient's parent) on 25 November 2013. A 19-month-old male patient whose medical history and concomitant medication were not reported, had received a dose of flu vaccine (lot number, dose number, route and anatomical site of administration were not reported) on 15 October year not reported. The patient was healthy at the time of vaccination. 35 days later on an unspecified date, the patient died. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Death
Clinical narrative: Initial report received from a non-healthcare professional (patient's parent) on 25 November 2013. A 19-month-old male patient whose medical history and concomitant medication were not reported, had received a dose of flu vaccine (lot number, dose number, route and anatomical site of administration were not reported) on 15 October year not reported. The patient was healthy at the time of vaccination. 35 days later on an unspecified date, the patient died. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: FLU3, FLU3, FLU3
Symptoms: Coma, Death, Laboratory test, Reye's syndrome
Clinical narrative: Initial report received from a non-healthcare professional (patient's parent) on 25 November 2013. A 19-month-old male patient whose medical history and concomitant medication were not reported, had received a dose of flu vaccine (lot number, dose number, route and anatomical site of administration were not reported) on 15 October year not reported. The patient was healthy at the time of vaccination. 35 days later on an unspecified date, the patient died. Documents held by sender: None.
Age: 77.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Erythema, Local swelling, Skin warm
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 77 year old female patient. On 19-NOV-2013, the patient was vaccinated with PNEUMOVAX23 lot # J007786 (expiry date: 25-SEP-2014), intramuscularly. No concomitant medications were reported. On 20-NOV-2013, the patient experienced injection site reactions. The reporter also reported that 3 other patients also experienced injections site reactions following the vaccination with PNEUMOVAX23. The patient sought medical attention and contacted the pharmacist. The reporter described reaction as red swollen upper and lower arm at the injections site. Approximately on 25-NOV-2013 (reported as within 5 to 6 days), the patient recovered from the event. Causality was not provided. This is one of the four reports from the same source. Additional information has been requested.
Age: 77.0
Sex: F
Vaccine: FLU3, PPV, PPV
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 77 year old female patient. On 19-NOV-2013, the patient was vaccinated with PNEUMOVAX23 lot # J007786 (expiry date: 25-SEP-2014), intramuscularly. No concomitant medications were reported. On 20-NOV-2013, the patient experienced injection site reactions. The reporter also reported that 3 other patients also experienced injections site reactions following the vaccination with PNEUMOVAX23. The patient sought medical attention and contacted the pharmacist. The reporter described reaction as red swollen upper and lower arm at the injections site. Approximately on 25-NOV-2013 (reported as within 5 to 6 days), the patient recovered from the event. Causality was not provided. This is one of the four reports from the same source. Additional information has been requested.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: I spoke with patient on 11/22/13 at about 6 pm.  Patient reported injection site reaction.  Redness, itching a little warmth, site about 2 1/2 inch by 1 1/4 inch at site of injection.  I called Merck to ask how long it will last as patient asked that question. They said it happens in 48% of patients vs 17% in placebo.  It last an average of 3.7 to 9.7 days. I told patient to call back if more severe.  Patient called back on 11/27/13 and reported that she was treated with an antibiotic by her primary doctor for cellulitis.
Age: 62.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cellulitis, Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: I spoke with patient on 11/22/13 at about 6 pm.  Patient reported injection site reaction.  Redness, itching a little warmth, site about 2 1/2 inch by 1 1/4 inch at site of injection.  I called Merck to ask how long it will last as patient asked that question. They said it happens in 48% of patients vs 17% in placebo.  It last an average of 3.7 to 9.7 days. I told patient to call back if more severe.  Patient called back on 11/27/13 and reported that she was treated with an antibiotic by her primary doctor for cellulitis.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Blindness, Blood test, Computerised tomogram head, Computerised tomogram thorax, Dysarthria
Clinical narrative: Rash on neck and chest, left arm went numb. Injection site was left deltoid.  Nov 8th, 2013 went to ER for severe allergic reaction. Throat closing, blurred vision/no vision, left side was paralyzed. Slurred speech, pain throughout entire body. Heart racing.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Hemiplegia, Hypersensitivity, Hypoaesthesia, Pain, Palpitations
Clinical narrative: Rash on neck and chest, left arm went numb. Injection site was left deltoid.  Nov 8th, 2013 went to ER for severe allergic reaction. Throat closing, blurred vision/no vision, left side was paralyzed. Slurred speech, pain throughout entire body. Heart racing.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Rash, Throat tightness, Urine analysis, Vision blurred
Clinical narrative: Rash on neck and chest, left arm went numb. Injection site was left deltoid.  Nov 8th, 2013 went to ER for severe allergic reaction. Throat closing, blurred vision/no vision, left side was paralyzed. Slurred speech, pain throughout entire body. Heart racing.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Chest discomfort, Dizziness, Headache, Night sweats
Clinical narrative: Fever, dizziness, headache, weakness, night sweats persisting for 4 weeks now and beginning to include chest tightness.
Age: 30.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: Fever, dizziness, headache, weakness, night sweats persisting for 4 weeks now and beginning to include chest tightness.
Age: 13.0
Sex: F
Vaccine: HPVX
Symptoms: Aggression, Pallor, Syncope
Clinical narrative: Fainted 5 minutes after vaccine given. Came to combative, very pale and took 30 minutes to feel "ok".
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 64 year old female patient. On 11-NOV-2013, the patient was vaccinated with PNEUMOVAX23 lot # J007786 (expiry date: 25-SEP-2014), intramuscularly. No concomitant medications were reported. On 12-NOV-2013, the patient experienced injection site reactions. The reporter also reported that 3 other patients also experienced injections site reactions following the vaccination with PNEUMOVAX23. The patient sought medical attention and contacted the pharmacist. The reporter described reaction as red swollen upper and lower arm at the injections site. Approximately on 17-NOV-2013 (reported as within 5 to 6 days), the patient recovered from the event. This is one of the four reports from the same source. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Haematochezia
Clinical narrative: This spontaneous report as received from an office's vaccine coordinator via field representative refers to a patient of unknown demographics. On an unknown date in November 2013 the patient was vaccinated with ROTATEQ vial standard second dose orally for prevention of rotavirus. Dose, lot number and expiry date were unknown. On an unknown date in November 2013, the patient developed blood in stool after vaccination. The field representative had made an attempt to report these events within the 24 hour reporting period on Wednesday 27-NOV-2013 however was unable to connect with the after-hours reporting system to leave a message. The outcome of blood in stool is unknown. The field representative mentioned that the events described in this report and the linked case (1312USA001477) occurred with patients who were administered ROTATEQ from the same unspecified lot number and expiry date. This is 1 of 2 reports from the same reporter. Additional information has been requested.
Age: 56.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Injection site swelling, Local swelling
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 56 year old female patient. On 20-NOV-2013, the patient was vaccinated with PNEUMOVAX23 lot # J007786 (expiry date: 25-SEP-2014), intramuscularly. No concomitant medications were reported. On 21-NOV-2013, the patient experienced injection site reactions. The reporter also reported that 3 other patients also experienced injections site reactions following the vaccination with PNEUMOVAX23. The patient sought medical attention and contacted the pharmacist. The reporter described reaction as red swollen upper and lower arm at the injections site. Approximately on 26-NOV-2013 (reported as within 5 to 6 days), the patient recovered from the event. Causality was not provided. This is one of the four reports from the same source. Additional information has been requested.
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Injection site swelling, Local swelling
Clinical narrative: This spontaneous report as received from a pharmacist refers to a 65 year old female patient. On 11-NOV-2013, the patient was vaccinated with PNEUMOVAX23 lot # J007786 (expiry date: 25-SEP-2014), intramuscularly. No concomitant medications were reported. On 12-NOV-2013, the patient experienced injection site reactions. The reporter also reported that 3 other patients also experienced injections site reactions following the vaccination with PNEUMOVAX23. The patient sought medical attention and contacted the pharmacist. The reporter described reaction as red swollen upper and lower arm at the injections site. Approximately on 17-NOV-2013 (reported as within 5 to 6 days), the patient recovered from the event. Causality was not provided. This is one of the four reports from the same source. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 02-DEC-2013 the patient was vaccinated with ZOSTAVAX vial of lot # J001729 expiry date 02-DEC-2013 single dose of 0.65 milliliters, via subcutaneous route. An expired dose was administered to the patient on that day. No adverse effect was reported. Additional information has been requested.
Age: 61.0
Sex: F
Vaccine: PPV
Symptoms: Local swelling, Skin warm
Clinical narrative: This spontaneous report as received from a nurse refers to a 61 year old female patient. Approximately in 1990, the patient was vaccinated with 2 doses of PNEUMOVAX23 (reported as Pneumonia vaccine). Dose and route were unspecified. No concomitant medications were reported. On an unknown date, the patient experienced severe arm swelling. It was described that the entire arm was swollen and hot to touch. The outcome of severe arm swelling was reported as recovered/resolved. Causality to the event was not provided. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Vomiting
Clinical narrative: This spontaneous report as received from an office's vaccine coordinator via field representative refers to a patient of unknown demographics. On an unknown date in November 2013 the patient was vaccinated with ROTATEQ vial standard  second dose orally. Dose, lot number and expiry date were known. On an unknown date in November 2013, the patient developed vomiting after vaccination. The field representative had made an attempt to report these events within the 24 hour reporting period on Wednesday 27-NOV-2013 however was unable to connect with the after-hours reporting system to leave a message. The outcome of vomiting was unknown. The field representative mentioned that the events described in this report and the linked case (1312USA001450) occurred with patients who were administered ROTATEQ from the same unspecified lot number and expiry date. This is 2 of 2 reports from the same reporter. additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Expired drug administered, No adverse event
Clinical narrative: Information was received from a registered nurse concerning a patient (demographics not provided), who on 09-OCT-2013, was vaccinated with an expired dose of ROTATEQ lot # 0278AE, expiration date 21-SEP-2013. This was the first dose in the ROTATEQ series. No adverse effects were reported. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report was received from a physician concerning an unspecified number of patients of unknown gender and age. On an unknown date the patients were vaccinated with ZOSTAVAX vial 19400 PFU. The physician reported that he had been purchasing ZOSTAVAX for about three years. He stated that he had a freezer in his office, so he freezes the gel packs which accompany his ZOSTAVAX shipments and store them that way while in the office. He stated that he then transports them to and from his home every day where they were stored in a residential freezer that did not have a thermometer that he stated that he believed was colder than 32 F. No adverse events were reported. Additional information is not expected.
Age: 25.0
Sex: F
Vaccine: HPV4, PPV
Symptoms: Malaise
Clinical narrative: This spontaneous report was received from a 25 year old female patient via Company Representative. On 05-OCT-2013 the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route, lot # and expiration date not reported). Other suspect therapies included a dose of GARDASIL (dose, route, lot # and expiration date not reported). It was reported that the patient felt sick after receiving 4 vaccines including GARDASIL and PNEUMOVAX 23. The patient felt sick on the night of the vaccination but recovered later. Additional information is not expected.
Age: 70.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash pustular
Clinical narrative: This spontaneous report was received from a pharmacist concerning a 70 year old male patient with high cholesterol and no drug reactions/allergies. On 03-MAY-2013, the patient was vaccinated with a dose of ZOSTAVAX, (vial 19400 PFU) (lot # H012576, expiration date: 28-SEP-2013), 0.65 ml, subcutaneous. Concomitant therapies included LIPTIOR (generic). The pharmacist reported that the patient developed a rash which may have contained pustules at an unspecified site on his body on an unspecified date. Patient sought medical attention at his physician's office on 26-AUG-2013. The patient was treated with VALTREX. VZVIP packet was declined. The outcome of event was reported as recovered/resolved. This is one of several reports from the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender. On 08-OCT-2013, the patient was inadvertently vaccinated with a intramuscularly 0.5ml dose of PNEUMOVAX23 (route and dose not reported) (Lot # 671680/1489AA) that had expired on 12-MAY-2013. No adverse effects reported. This is one of five reports concerning the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender. On 07-OCT-2013, the patient was inadvertently vaccinated with a intramuscularly 0.5 ml dose of PNEUMOVAX23 (route and dose not reported) (Lot # 671680/1489AA) that had expired on 12-MAY-2013. No adverse effects reported. This is one of five reports concerning the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender. On 08-OCT-2013, the patient was inadvertently vaccinated with a intramuscularly 0.5 ml dose of PNEUMOVAX23 (route and dose not reported) (Lot # 671680/1489AA) that had expired on 12-MAY-2013. No adverse effects reported. This is one of five reports concerning the same source. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Asthenia, Blood glucose decreased, Blood test normal, Chest pain, Confusional state
Clinical narrative: This spontaneous report as received from a physician concerning a 24 year old female patient with type 1 diabetes and no drug reactions/allergies. On 17-SEP-2013 the patient was vaccinated with the first dose of GARDASIL (lot # J006850; expiration date: 31-MAR-2016), 0.5 ml, subcutaneous. Concomitant therapies included insulin and ethinyl estradiol, MICROGESTIN and insulin. The physician reported that on 29-OCT-2013, the patient had an episode of confusion, at which time the patient's blood sugar was taken and determined to be 50 (units unknown). On an unspecified date after this episode of confusion, the patient developed severe muscle aching in her lower extremities and she became very weak. The patient was currently very fatigued when walking and was unable to get up fully. The patient went to see an unspecified neurologist on an unspecified date, who performed electromyogram studies, nerve conduction studies and unspecified blood studies, all of which returned normal results. The physician reported that the patient's leg pain had gotten a bit better to the point that is was not as uncomfortable as it was before. The outcome of confusion, patient unable to get up fully, severe muscle aching in her lower extremities and the patient's blood sugar abnormal were reported as recovering/resolving. At the time of the report, the patient continued having weakness, chest pain, arm pain, a positive Gower signs, and tiredness which made it difficult for her to work. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Dysstasia, Electromyogram normal, Fatigue, Impaired work ability, Myalgia
Clinical narrative: This spontaneous report as received from a physician concerning a 24 year old female patient with type 1 diabetes and no drug reactions/allergies. On 17-SEP-2013 the patient was vaccinated with the first dose of GARDASIL (lot # J006850; expiration date: 31-MAR-2016), 0.5 ml, subcutaneous. Concomitant therapies included insulin and ethinyl estradiol, MICROGESTIN and insulin. The physician reported that on 29-OCT-2013, the patient had an episode of confusion, at which time the patient's blood sugar was taken and determined to be 50 (units unknown). On an unspecified date after this episode of confusion, the patient developed severe muscle aching in her lower extremities and she became very weak. The patient was currently very fatigued when walking and was unable to get up fully. The patient went to see an unspecified neurologist on an unspecified date, who performed electromyogram studies, nerve conduction studies and unspecified blood studies, all of which returned normal results. The physician reported that the patient's leg pain had gotten a bit better to the point that is was not as uncomfortable as it was before. The outcome of confusion, patient unable to get up fully, severe muscle aching in her lower extremities and the patient's blood sugar abnormal were reported as recovering/resolving. At the time of the report, the patient continued having weakness, chest pain, arm pain, a positive Gower signs, and tiredness which made it difficult for her to work. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Nerve conduction studies normal, Pain in extremity
Clinical narrative: This spontaneous report as received from a physician concerning a 24 year old female patient with type 1 diabetes and no drug reactions/allergies. On 17-SEP-2013 the patient was vaccinated with the first dose of GARDASIL (lot # J006850; expiration date: 31-MAR-2016), 0.5 ml, subcutaneous. Concomitant therapies included insulin and ethinyl estradiol, MICROGESTIN and insulin. The physician reported that on 29-OCT-2013, the patient had an episode of confusion, at which time the patient's blood sugar was taken and determined to be 50 (units unknown). On an unspecified date after this episode of confusion, the patient developed severe muscle aching in her lower extremities and she became very weak. The patient was currently very fatigued when walking and was unable to get up fully. The patient went to see an unspecified neurologist on an unspecified date, who performed electromyogram studies, nerve conduction studies and unspecified blood studies, all of which returned normal results. The physician reported that the patient's leg pain had gotten a bit better to the point that is was not as uncomfortable as it was before. The outcome of confusion, patient unable to get up fully, severe muscle aching in her lower extremities and the patient's blood sugar abnormal were reported as recovering/resolving. At the time of the report, the patient continued having weakness, chest pain, arm pain, a positive Gower signs, and tiredness which made it difficult for her to work. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug
Clinical narrative: This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown demographics. On unknown date in 2013, unspecified number of patients were vaccinated with GARDASIL. These doses were from GARDASIL that was exposed to multiple excursions of less than 32F over the course of the month of September 2013. At the time of this call, the healthcare worker did not have the lot numbers or the administration information available, since the excursions and administrators occurred at another facility and was supposed to gather the details of the dates of the excursions, the nature of the excursions, the lot numbers of the doses that were administered, the dates of administration, and the patient identifiers, and fax them. No additional information was available at this time. Additional information has been requested.
Age: 58.0
Sex: M
Vaccine: HEPAB
Symptoms: Borrelia test negative, VIIth nerve paralysis
Clinical narrative: Bell's palsy diagnosed on 11/13/13. Prescribed Prednisone, doxycycline and VALTREX. Lyme disease antibody ordered - negative. 11/25/13 - Follow-up appointment. 11/27/13 - Seen by ophthalmologist.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Adverse drug reaction, Allergy to vaccine
Clinical narrative: This spontaneous report as received from a licensed practical nurse refers to a licensed practical nurse and refers to 20 years old (previously reported as 16 years old)non pregnant female patient with gravidity 0, parity 0, and drug reactions/allergy to aspirin, MOTRIN. On an unknown date the patient was vaccinated with the dose of GARDASIL (dose, frequency, route of administration and lot number were not reported). On an unknown date the patient experienced drug reaction or allergy on GARDASIL injection. The outcome of the patient event was unknown. The relatedness between the event and GARDASIL was not reported. This case is linked with 1310USA0014123, considered the same patient. Additional information has been requested.
Age: 2.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Pyrexia, Streptococcal infection
Clinical narrative: Fever x 2 days highest 106 - 11/30 12/1 warm tender leg where immunization was given. 2 x 4 cm erythema left leg.
Age: 2.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Streptococcus test, Streptococcus test positive
Clinical narrative: Fever x 2 days highest 106 - 11/30 12/1 warm tender leg where immunization was given. 2 x 4 cm erythema left leg.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender. On 14-OCT-2013, the patient was inadvertently vaccinated with an intramuscularly 0.5 ml dose of PNEUMOVAX23 (route and dose not reported) (Lot # 671680/1489AA) that had expired on 12-MAY-2013. No adverse effects reported. This is one of five reports concerning the same source. Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report was received from a Registered Nurse concerning a patient of unknown age and gender. On 09-OCT-2013, the patient was inadvertently vaccinated with an intramuscularly 0.5 ml dose of PNEUMOVAX23 (route and dose not reported) (Lot # 671680/1489AA) that had expired on 12-MAY-2013. No adverse effects reported. this is one of five reports concerning the same source. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: This spontaneous report as received form a pharmacist via Company Representative concerning a female patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, lot number and expiration date not reported), subcutaneous. It was reported that the patient developed an injection site reaction that was larger than normal after receiving ZOSTAVAX which included redness, swelling and warmth. Patient's outcome was unknown. The patient sought medical attention by talking to the pharmacy. Additional information has been requested.
Age: 55.0
Sex: F
Vaccine: FLUX
Symptoms: Joint range of motion decreased, Musculoskeletal stiffness, Pain in extremity
Clinical narrative: Pain and stiffness in upper arm that persisted for over 1 month, could not raise arm over over height, could not sleep on left side due to pain,  it 's now 12/4/2013 and slowly getting better.  Still some soreness.  Please see website on link, many people have the same complaint, my opinion is the issue is with the injection was placed incorrectly on the arm. Is this condition considered SIRVA? Mine was done at a free clinic. I think student nurses did the shot administration so maybe additional training and supervision is needed.  I never had a problem in the past (other than a day or 2 soreness). If this problem happens enough I would think people who are hesitant to begin with will not get a shot in the future.
Age: 47.0
Sex: M
Vaccine: FLU3
Symptoms: Nausea, Tinnitus, Vertigo
Clinical narrative: 24 hours after receiving the flu vaccine, the patient developed nausea and vertigo. He has had lingering symptoms of tinnitus since that time.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Eye pain, Headache
Clinical narrative: Pain and sensitivity near right eye and side of head.  Described as "like an electric prod" in the right temporal area and above the right eye.  This has continued intermittently and was present at time of 12/02/13 office visit.  No herpetic rash.  No PH herpetic rash.  No PH of trigeminal neuralgia.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Hives, developed all over the body throughout the day.  Very itchy, red.  Prednisone orally, antihistamines.
Age: 16.0
Sex: M
Vaccine: HEPA, HPV4
Symptoms: Injection site pain, Loss of consciousness
Clinical narrative: AFTER RECEIVING THE HPV VACCINE THE PATIENT INDICATED THAT IT HURT. AFTER RECEIVING THE OTHER VACCINE IN THE OTHER ARM THE PATIENT LOST CONSCIOUSNESS FOR A FEW SECONDS. THE DOCTOR INDICATED THE MOTHER TO TAKE HER SON TO THE HOSPITAL.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Aphagia, Back pain, Chills, Headache
Clinical narrative: Severe chills- could not get body temperature normal until late nighttime; headache; backache; headache; nausea; digestive discomfort; unable to eat for 2 days.
Age: 67.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea
Clinical narrative: Severe chills- could not get body temperature normal until late nighttime; headache; backache; headache; nausea; digestive discomfort; unable to eat for 2 days.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Patient reports no signs/symptoms or issues after receiving inactive influenza vaccine on 11/13/13 until 2 weeks later on 11/27/13 client complained of "raised, swollen, tender bump around area of injection site". Patient saw MD on 12/3/13 and given treatment of Advil and hot compresses. Patient reports the symptoms are getting better and will follow up with MD in one week if symptoms persist.
Age: 1.08
Sex: F
Vaccine: FLU3, MMR, VARCEL
Symptoms: Injection site erythema, Injection site reaction, Skin lesion
Clinical narrative: (R) thigh is red 1 cm raised lesions with central pronounced not vesicular but ? at site varicella or flu vac.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Induration
Clinical narrative: Patient had area redness 2 1/2 by 3 inches with 1 1/2 by 1 3/4 induration.
Age: 66.0
Sex: F
Vaccine: FLUC3, VARZOS
Symptoms: Dysphagia, Injection site swelling
Clinical narrative: Extreme swelling at injection site, and slight problem swallowing --> patient started recovering on 11/21/13 after being seen at Urgent Care on 11/20/13. She was given Prednisone one tablet every day x 5 days.
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Addison's disease, Asthenia, Blood test normal, Cold sweat, Decreased appetite
Clinical narrative: Shortness of breath - dizzy = Saturday clammy, shortness of breath - heart palpitations weak - Sunday, stayed home Monday DR's appt when back to emergency (was there Sunday), went to work Wed - was sent home. 11-15-13 = started Friday = no appetite - shortness of breath, dizzy = Sat. (went to work) clammy, heart palpitations - nausea 11-16-13 Sunday = 11-17-13 (went to work 1/2 day) clammy, dizzy, heart palpitations - nausea - dry heaves (at home in AM) also no appetite went to emergency room. Was given an EKG - blood tests, I.V. Was sent home everything was O.K. I wasn't! Monday called in made appointment to see doctor, she gave me a release to go back to work Wednesday 11-20. Was told to go home until I was 100% - whatever that is?? or whenever?? I have Addison's disease for which I take Prednisone - have been taking this for many years. I was told by my immunology - she told me to retake this Pneumonia vaccine because my immune system is in trouble. I did take this vaccine when I turned 60 - had no problems then. I have enclosed a list of my medications. Besides Addison disease, I have gastritis, gastric ulcer, hiatal hernia and diverticulitis. If this information needs more explanation call me before Dec. 16 - I'm going back to work Dec. 3. I have a DR's appointment and Dec. 6 I'm having a procedure done. So feel free to call before or after the 3rd and 6th. I'm still not feeling right - very tired - no energy?!!??!
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Diverticulitis, Dizziness, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Shortness of breath - dizzy = Saturday clammy, shortness of breath - heart palpitations weak - Sunday, stayed home Monday DR's appt when back to emergency (was there Sunday), went to work Wed - was sent home. 11-15-13 = started Friday = no appetite - shortness of breath, dizzy = Sat. (went to work) clammy, heart palpitations - nausea 11-16-13 Sunday = 11-17-13 (went to work 1/2 day) clammy, dizzy, heart palpitations - nausea - dry heaves (at home in AM) also no appetite went to emergency room. Was given an EKG - blood tests, I.V. Was sent home everything was O.K. I wasn't! Monday called in made appointment to see doctor, she gave me a release to go back to work Wednesday 11-20. Was told to go home until I was 100% - whatever that is?? or whenever?? I have Addison's disease for which I take Prednisone - have been taking this for many years. I was told by my immunology - she told me to retake this Pneumonia vaccine because my immune system is in trouble. I did take this vaccine when I turned 60 - had no problems then. I have enclosed a list of my medications. Besides Addison disease, I have gastritis, gastric ulcer, hiatal hernia and diverticulitis. If this information needs more explanation call me before Dec. 16 - I'm going back to work Dec. 3. I have a DR's appointment and Dec. 6 I'm having a procedure done. So feel free to call before or after the 3rd and 6th. I'm still not feeling right - very tired - no energy?!!??!
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Gastric ulcer, Gastritis, Heart rate decreased, Hiatus hernia, Nausea
Clinical narrative: Shortness of breath - dizzy = Saturday clammy, shortness of breath - heart palpitations weak - Sunday, stayed home Monday DR's appt when back to emergency (was there Sunday), went to work Wed - was sent home. 11-15-13 = started Friday = no appetite - shortness of breath, dizzy = Sat. (went to work) clammy, heart palpitations - nausea 11-16-13 Sunday = 11-17-13 (went to work 1/2 day) clammy, dizzy, heart palpitations - nausea - dry heaves (at home in AM) also no appetite went to emergency room. Was given an EKG - blood tests, I.V. Was sent home everything was O.K. I wasn't! Monday called in made appointment to see doctor, she gave me a release to go back to work Wednesday 11-20. Was told to go home until I was 100% - whatever that is?? or whenever?? I have Addison's disease for which I take Prednisone - have been taking this for many years. I was told by my immunology - she told me to retake this Pneumonia vaccine because my immune system is in trouble. I did take this vaccine when I turned 60 - had no problems then. I have enclosed a list of my medications. Besides Addison disease, I have gastritis, gastric ulcer, hiatal hernia and diverticulitis. If this information needs more explanation call me before Dec. 16 - I'm going back to work Dec. 3. I have a DR's appointment and Dec. 6 I'm having a procedure done. So feel free to call before or after the 3rd and 6th. I'm still not feeling right - very tired - no energy?!!??!
Age: 64.0
Sex: F
Vaccine: PPV
Symptoms: Palpitations, Retching
Clinical narrative: Shortness of breath - dizzy = Saturday clammy, shortness of breath - heart palpitations weak - Sunday, stayed home Monday DR's appt when back to emergency (was there Sunday), went to work Wed - was sent home. 11-15-13 = started Friday = no appetite - shortness of breath, dizzy = Sat. (went to work) clammy, heart palpitations - nausea 11-16-13 Sunday = 11-17-13 (went to work 1/2 day) clammy, dizzy, heart palpitations - nausea - dry heaves (at home in AM) also no appetite went to emergency room. Was given an EKG - blood tests, I.V. Was sent home everything was O.K. I wasn't! Monday called in made appointment to see doctor, she gave me a release to go back to work Wednesday 11-20. Was told to go home until I was 100% - whatever that is?? or whenever?? I have Addison's disease for which I take Prednisone - have been taking this for many years. I was told by my immunology - she told me to retake this Pneumonia vaccine because my immune system is in trouble. I did take this vaccine when I turned 60 - had no problems then. I have enclosed a list of my medications. Besides Addison disease, I have gastritis, gastric ulcer, hiatal hernia and diverticulitis. If this information needs more explanation call me before Dec. 16 - I'm going back to work Dec. 3. I have a DR's appointment and Dec. 6 I'm having a procedure done. So feel free to call before or after the 3rd and 6th. I'm still not feeling right - very tired - no energy?!!??!
Age: 67.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Malaise, Nausea
Clinical narrative: Patient developed redness, swelling and fever at injection site on left arm Friday afternoon. Developed nausea and vomiting on Sunday. And overall does not feel well. The injection site was doing better when the phone call was received on Monday 11/25/2013.
Age: 67.0
Sex: M
Vaccine: FLU3
Symptoms: Vomiting
Clinical narrative: Patient developed redness, swelling and fever at injection site on left arm Friday afternoon. Developed nausea and vomiting on Sunday. And overall does not feel well. The injection site was doing better when the phone call was received on Monday 11/25/2013.
Age: 0.08
Sex: F
Vaccine: HIBV, RV5
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: Information was received from a physician regarding a 4 week old female patient. On 18-OCT-2013, the 4 week old patient was vaccinated with Liquid PEDVAXHIB, 0.5 ml, intramuscularly in the left thigh. On 18-OCT-2013, the patient was also vaccinated with ROTATEQ, 2 ml. No adverse effects reported at this time. Additional information is not expected.
Sex: M
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling, Nausea, Neck pain, Pain
Clinical narrative: This case was reported by a pharmacist via Pharmacy Risk Management General Liability and described the occurrence of nausea in an adult male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 28 October 2013 the subject received a dose of FLULAVAL (unknown, left arm). In October 2013, within days of vaccination with FLULAVAL, the subject experienced nausea and pain. Medications prescribed from visit to the primary care physician included Promethazine 25mg for symptoms of nausea after the flu shot administered on 28 October 2013; was told to take TYLENOL for pain. On 01 November 2013, four days after vaccination with FLULAVAL, the subject experienced injection site arm pain radiating to anterior neck, pain radiating up arm, skin infection and swelling at injection site area. On 01 November 2013, four days after vaccination, the subject presented to the emergency room (ER) for severe pain that traveled from the upper left arm where the shot was administered to the left shoulder and left side of the neck. Also developed a skin infection and swelling in the left arm surrounding the area where the flu shot was administered. The subject received KEFLEX 500mg four times daily, BACTRIM DS 800/120 mg twice daily, MOTRIN 800 mg three times daily and PERCOCET 5/325 one to two pills every six hours. The intravenous medications the subject received in the ER included Morphine, ZOFRAN, TORADOL (two) antibiotic ROCEPHIN and Doxy. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events were unspecified.
Sex: M
Vaccine: FLU3
Symptoms: Pain in extremity, Skin infection, Vaccination site reaction
Clinical narrative: This case was reported by a pharmacist via Pharmacy Risk Management General Liability and described the occurrence of nausea in an adult male subject who was vaccinated with FLULAVAL (GlaxoSmithKline). On 28 October 2013 the subject received a dose of FLULAVAL (unknown, left arm). In October 2013, within days of vaccination with FLULAVAL, the subject experienced nausea and pain. Medications prescribed from visit to the primary care physician included Promethazine 25mg for symptoms of nausea after the flu shot administered on 28 October 2013; was told to take TYLENOL for pain. On 01 November 2013, four days after vaccination with FLULAVAL, the subject experienced injection site arm pain radiating to anterior neck, pain radiating up arm, skin infection and swelling at injection site area. On 01 November 2013, four days after vaccination, the subject presented to the emergency room (ER) for severe pain that traveled from the upper left arm where the shot was administered to the left shoulder and left side of the neck. Also developed a skin infection and swelling in the left arm surrounding the area where the flu shot was administered. The subject received KEFLEX 500mg four times daily, BACTRIM DS 800/120 mg twice daily, MOTRIN 800 mg three times daily and PERCOCET 5/325 one to two pills every six hours. The intravenous medications the subject received in the ER included Morphine, ZOFRAN, TORADOL (two) antibiotic ROCEPHIN and Doxy. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the events were unspecified.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Dizziness, Hypersensitivity, Hypertension, Urticaria
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of allergic reaction in a subject of unspecified age and gender who was vaccinated with influenza (GlaxoSmithKline). On 18 October 2013 the subject received a dose of influenza (unknown details). It was unclear from the report if the subject received trivalent or quadrivalent formulation. On 18 October 2013, 30 minutes after vaccination with influenza, the subject experienced allergic reaction. No further details were provided. At the time of reporting the outcome of the event was unspecified. Follow-up information was received on 25 November 2013 via nurse who reported the 24-year-old female subject was vaccinated with FLULAVAL (.5 ml, intramuscular, unknown deltoid) on 18 October 2013. On 18 October 2013, 30 minutes after vaccination with FLULAVAL, the subject experienced allergic reaction; symptoms included urticaria, dizziness and hypertension. The nurse reported the subject got light headed about 30 minutes post injection with FLULAVAL. Her blood pressure was 150/70 and she got hives. She was treated at the emergency room with steroids and discharge home on prednisone and BENADRYL. The subject had not previously received FLULAVAL; it was withdrawn and not reintroduced. On 25 October 2013, the events were resolved and the subject made a full recovery. The subject took steroids for four to five days post event. The reporting healthcare professional considered the events serious such as clinically significant (or requiring intervention), as well as potentially life threatening.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Herpes zoster, Impaired work ability
Clinical narrative: This case was reported by a healthcare professional (nurse) via sales representative and described the occurrence of shingles (1) side of face in a 50-year-old male subject who was vaccinated with FLUARIX (unspecified formulation) (GlaxoSmithKline). In October 2013 the subject received a dose of FLUARIX (.5 ml, intramuscular, unknown deltoid). In October 2013, 1 day after vaccination with FLUARIX, the subject experienced shingles (1) side of face. In October 2013, within a month after vaccination with FLUARIX, the subject experienced could not work (nos). The shingles were located on the left side of the subject's face and scalp. As a result of the shingles, the subject sought medical attention and "had to miss one day of work". At the time of reporting the outcome of the events were unspecified. The healthcare professional considered the events were possibly related to vaccination with FLUARIX. Follow up was received from nurse via sales representative on 29 October 2013. The lot number provided identified the FLUARIX as the trivalent formulation. Per the nurse, on 3 October 2013, the subject received a dose of FLUARIX (unknown details). On 4 October 2013, one day after vaccination with FLUARIX, the subject experienced shingles. No further details were provided. Follow-up information was received on 26 November 2013 via nurse who reported the 50-year-old male subject was vaccinated with FLUARIX (.5 ml, intramuscular, right deltoid) on 3 October 2013. No action was taken with FLUARIX. The events occurred 4 October 2013 and resolved on 18 October 2013. The healthcare professional considered the events serious, however she did not indicate the specific seriousness assessment for the events. At the time of the report no other information was provided.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy, Muscular weakness, Paralysis
Clinical narrative: Muscle weakness initially, progressing to Guillain-Barre paralysis by 14 days post vaccination. History of Guillain-Barre after episode of shingles last year (2012). Pt required 5 doses of IVIG, PT/OT, Home RN after discharge.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth, Rash, Rash macular
Clinical narrative: Rt upper arm region 4.5x 4.5mm--injection site is red, itchy, warm--no systemic symptoms, lasted 1 week. On 10/1/2013 itchy, macular rash developed on rt upper arm, armpit extending into side of torso. Side effects ended about 2 weeks ago--the week of November 17, 2013.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash pruritic
Clinical narrative: Rt upper arm region 4.5x 4.5mm--injection site is red, itchy, warm--no systemic symptoms, lasted 1 week. On 10/1/2013 itchy, macular rash developed on rt upper arm, armpit extending into side of torso. Side effects ended about 2 weeks ago--the week of November 17, 2013.
Age: 25.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Inflammation, Pain in extremity, Pruritus, Skin warm
Clinical narrative: PATIENT REFERS THAT THE LEFT ARM ITCHES AND HURTS. THE AREA APPEARS RED, WITH INFLAMMATION AND HOT TO THE TOUCH. THE PATIENT WAS EVALUATED BY DR. SHE ORDERED ARICEPT AND NAPROXEN.
Age: 60.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Muscular weakness, Musculoskeletal discomfort
Clinical narrative: Vague muscle discomfort/weakness in legs, arms, and back.  Continued symptoms this morning, (12/04/2013).
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Pain, Pruritus, Swelling, Ultrasound scan
Clinical narrative: 2 hours after immunization, itching and swelling, pain below injection site. Pt went to express care. Prescribed doxycycline 100mg and KEFLEX 500. Had ultrasound to rule out clot?
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain
Clinical narrative: Pain in left upper arm, worse at night no redness, warmth, full ROM.
Age: 16.0
Sex: M
Vaccine: HPV4
Symptoms: Abdominal pain upper, Blood test, Computerised tomogram, Convulsion, Dyspnoea
Clinical narrative: Headache, numbness of extremities, stomach ache, trouble breathing, stopped breathing, seizures, on ventilator, had CT scan, MRI, EEG, EKG, spinal tap, IV antibiotics, antivirals, blood clots, blood thinners.
Age: 16.0
Sex: M
Vaccine: HPV4
Symptoms: Electrocardiogram, Electroencephalogram, Headache, Hypoaesthesia, Lumbar puncture
Clinical narrative: Headache, numbness of extremities, stomach ache, trouble breathing, stopped breathing, seizures, on ventilator, had CT scan, MRI, EEG, EKG, spinal tap, IV antibiotics, antivirals, blood clots, blood thinners.
Age: 16.0
Sex: M
Vaccine: HPV4
Symptoms: Mechanical ventilation, Nuclear magnetic resonance imaging, Respiratory arrest, Thrombosis
Clinical narrative: Headache, numbness of extremities, stomach ache, trouble breathing, stopped breathing, seizures, on ventilator, had CT scan, MRI, EEG, EKG, spinal tap, IV antibiotics, antivirals, blood clots, blood thinners.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: Severe leg pain within minutes after receiving vaccine, numbness all has progressively gotten worse.
Age: 11.0
Sex: F
Vaccine: MEN, TDAP
Symptoms: Throat tightness
Clinical narrative: Patient complained tightness of her throat.  No difficulty breathing no edema noted, no rash or redness.